Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahimeh Varzideh

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|September 9, 2021
Advances in the understanding of excitation-contraction coupling: the pulsing quest for drugs against heart failure and arrhythmiasUrna Kansakar, Fahimeh Varzideh, Stanislovas S Jankauskas, et al.
International Journal of Molecular Sciences|February 13, 2026
Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 DiabetesUrna Kansakar, Stanislovas S Jankauskas, Shivangi Pande, et al.
JACC. Basic to Translational Science|April 12, 2022
Exosome-Mediated Angiogenesis Underlies LVAD-Induced Bleeding in Patients With End-Stage Heart FailurePasquale Mone, Antonella Pansini, Fahimeh Varzideh, et al.
Journal of Molecular and Cellular Cardiology Plus|January 13, 2025
Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failureFahimeh Varzideh, Pasquale Mone, Luigi Salemme, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2022
Epidemiology of obstructive sleep apnea: What is the contribution of hypertension and arterial stiffness?Pasquale Mone, Urna Kansakar, Fahimeh Varzideh, et al.
Atherosclerosis|November 17, 2025
Unmasking the genetic double agents of hyperglycemia: Mendelian randomization in endotheli-hell espionageShivangi Pande, Fahimeh Varzideh, George Ishak, et al.
International Journal of Molecular Sciences|February 13, 2025
Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic PotentialCheryl Tung, Fahimeh Varzideh, Emanuele Farroni, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2022
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic PatientsPasquale Mone, Fahimeh Varzideh, Stanislovas S Jankauskas, et al.
Vascular Pharmacology|July 10, 2024
Ketogenic diet improves chromatin remodeling and rescues mitochondrial dysfunction in ischemic heart disease by regulating PGC-1alpha transcriptionJessica Gambardella, Fahimeh Varzideh, Stanislovas S Jankauskas, et al.
Military Medical Research|January 3, 2024
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathyStanislovas S Jankauskas, Fahimeh Varzideh, Pasquale Mone, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
European Heart Journal. Cardiovascular Pharmacotherapy|September 9, 2021
Advances in the understanding of excitation-contraction coupling: the pulsing quest for drugs against heart failure and arrhythmiasUrna Kansakar, Fahimeh Varzideh, Stanislovas S Jankauskas, et al.
International Journal of Molecular Sciences|February 13, 2026
Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 DiabetesUrna Kansakar, Stanislovas S Jankauskas, Shivangi Pande, et al.
JACC. Basic to Translational Science|April 12, 2022
Exosome-Mediated Angiogenesis Underlies LVAD-Induced Bleeding in Patients With End-Stage Heart FailurePasquale Mone, Antonella Pansini, Fahimeh Varzideh, et al.
Journal of Molecular and Cellular Cardiology Plus|January 13, 2025
Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failureFahimeh Varzideh, Pasquale Mone, Luigi Salemme, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2022
Epidemiology of obstructive sleep apnea: What is the contribution of hypertension and arterial stiffness?Pasquale Mone, Urna Kansakar, Fahimeh Varzideh, et al.
Atherosclerosis|November 17, 2025
Unmasking the genetic double agents of hyperglycemia: Mendelian randomization in endotheli-hell espionageShivangi Pande, Fahimeh Varzideh, George Ishak, et al.
International Journal of Molecular Sciences|February 13, 2025
Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic PotentialCheryl Tung, Fahimeh Varzideh, Emanuele Farroni, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2022
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic PatientsPasquale Mone, Fahimeh Varzideh, Stanislovas S Jankauskas, et al.
Vascular Pharmacology|July 10, 2024
Ketogenic diet improves chromatin remodeling and rescues mitochondrial dysfunction in ischemic heart disease by regulating PGC-1alpha transcriptionJessica Gambardella, Fahimeh Varzideh, Stanislovas S Jankauskas, et al.
Military Medical Research|January 3, 2024
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathyStanislovas S Jankauskas, Fahimeh Varzideh, Pasquale Mone, et al.
Pageof 12